SCHEMBL8593449

SCHEMBL8593449

O=[C]NCCS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7637332 0.85 APP (0.42)
SCHEMBL3707353 0.74
SCHEMBL7533631 0.72
SCHEMBL1805336 0.71 PTGS1 (0.45)
SCHEMBL8481986 0.71 PTGS1 (0.45)
SCHEMBL3583741 0.70
SCHEMBL5473399 0.69
SCHEMBL3137447 0.69
SCHEMBL30026428 0.69 PTGS1 (0.43)
SCHEMBL19865717 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1668286-A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea ASTRAZENECA AB (SE) 2005-09-14 CN claimed
CN-1416425-A 1,5-bemzothiazepines and their use as hypolipidaemics ASTRAZENECA AB (SE) 2003-05-07 CN claimed
EP-0252004-A1 Pharmaceutical compositions for parenteral application CIBA-GEIGY AG (CH) 1988-01-07 EP claimed
EP-4364754-A2 ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES AbbVie Inc. (US) 2024-05-08 EP disclosed
EP-3514156-A1 2-SUBSTITUTED BENZOTHIAZOLYL-3-SUBSTITUTED PHENYL-5-SUBSTITUTED SULFONATED PHENYL-2H-TETRAZOLIUM SALT, BIOLOGICAL COMPONENT CONCENTRATION MEASUREMENT REAGENT CONTAINING SAID SALT, AND BIOLOGICAL COMPONENT CONCENTRATION MEASUREMENT METHOD USING SAID SALT Terumo Kabushiki Kaisha (JP) 2019-07-24 EP disclosed
US-10358567-B2 Compound, ink, ink cartridge and ink jet recording method CANON KABUSHIKI KAISHA (JP) 2019-07-23 US disclosed
CN-109963870-A ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES 艾伯维公司 2019-07-02 CN disclosed
CN-109600993-A Anti-EGFR antibody drug conjugates 艾伯维公司 2019-04-09 CN disclosed
CN-109563168-A ANTI-EGFR ANTIBODY DRUG CONJUGATES 艾伯维公司 2019-04-02 CN disclosed
CN-109562169-A anti-CD 98 antibodies and antibody drug conjugates 艾伯维公司 2019-04-02 CN disclosed
CN-109563167-A ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES 艾伯维公司 2019-04-02 CN disclosed
EP-0413314-A1 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1991-02-20 EP disclosed
EP-0409117-A1 Silver halide photographic material KONICA CORPORATION (JP) 1991-01-23 EP disclosed
US-4957856-A X-RAY FILMS HAVING A SUBBING LAYER COMPRISING A GELATIN BINDER, A CATIONIC ADDITION COPOLYMER, A PYRAZOLONE DYE AND A NONIONIC SURFACTANT; ANTIHALATION AGENTS FUJI PHOTO FILM CO., LTD. (JP) 1990-09-18 US disclosed
US-4933268-A OXONOL DYE HAVING PYRAZOLONE NUCLEUS FUJI PHOTO FILM CO., LTD. (JP) 1990-06-12 US disclosed
US-4906553-A Processing process for silver halide black and white photographic materials FUJI PHOTO FILM CO., LTD. (JP) 1990-03-06 US disclosed
EP-0341637-A2 Processing process for silver halide black and white photographic materials FUJI PHOTO FILM CO., LTD. (JP) 1989-11-15 EP disclosed
EP-0316013-A2 Silver halide photographic material having at least one dyed hydrophilic colloid layer Fuji Photo Film Co., Ltd. (JP) 1989-05-17 EP disclosed
US-4756993-A Light scattering layer comprises inorganic fine powder and binder or light absorbing layer comprising near infrared absorbing dye and binder FUJI PHOTO FILM CO., LTD. (JP) 1988-07-12 US disclosed
EP-0252004-A1 Pharmaceutical compositions for parenteral application CIBA-GEIGY AG (CH) 1988-01-07 EP disclosed